Back to search

Article

Combined genomic and molecular analysis defines prognostic markers of relapse in stage IA-IC1 clear cell ovarian carcinoma

2025-03-21

Abstract excerpt

<h4>Objective</h4> Clear cell ovarian carcinoma (CCOC) is generally associated with a favourable prognosis, but up to 30% of low-stage cases relapse within five years. The benefit of adjuvant chemotherapy for low-stage CCOC (FIGO stage IA-IC1) remains uncertain. This study aimed to identify molecular and immune markers associated with relapse in a well-characterized CCOC cohort. <h4>Methods</h4> Using the Edinbu...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
20bebd47-9138-5045-8be2-63ba032dfd86
DOI
10.1101/2025.03.20.644313
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Combined genomic and molecular analysis defines prognostic markers of relapse in stage IA-IC1 clear cell ovarian carcinomaDOI 10.1101/2025.03.20.644313
Combined genomic and molecular analysis defines prognostic markers of relapse in stage IA-IC1 clear cell ovarian carcinoma.Semantic proximity
Comprehensive characterization of genomic features and clinical outcomes following targeted therapy and secondary cytoreductive surgery in OCCC: a single center experience.Semantic proximity
Integrated genomic/epigenomic analysis stratifies subtypes of clear cell ovarian carcinoma, highlighting their cellular origin.Semantic proximity
Multiomic characterisation of high grade serous ovarian carcinoma enables high resolution patient stratificationSemantic proximity
Molecular Subclasses of Clear Cell Ovarian Carcinoma and Their Impact on Disease Behavior and Outcomes.Semantic proximity
APOBEC3B stratifies ovarian clear cell carcinoma with distinct immunophenotype and prognosis.Semantic proximity
Comprehensive molecular characterization identifies therapeutic vulnerabilities in ovarian clear cell carcinoma.Semantic proximity
The genomic landscape of recurrent ovarian high grade serous carcinoma: the BriTROC-1 studySemantic proximity
Myeloid cell networks determine reinstatement of original immune environments in recurrent ovarian cancerSemantic proximity
DNA Methylation and Transcriptomic Features are Preserved Throughout Disease Recurrence and Chemoresistance in High Grade Serous Ovarian CancersSemantic proximity
ARID1A mutation/ARID1A loss is associated with a high immunogenic profile in clear cell ovarian cancer.Semantic proximity
DNA Methylation Profiles of Ovarian Clear Cell Carcinoma.Semantic proximity
Select a neighboring publication to make it the new centre.